Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2017 | 1 |
2018 | 1 |
2021 | 2 |
2022 | 1 |
2023 | 2 |
2024 | 1 |
Search Results
7 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
PLCG2-associated immune dysregulation (PLAID) comprises broad and distinct clinical presentations related to functional classes of genetic variants.
J Allergy Clin Immunol. 2024 Jan;153(1):230-242. doi: 10.1016/j.jaci.2023.08.036. Epub 2023 Sep 26.
J Allergy Clin Immunol. 2024.
PMID: 37769878
Clinical Outcomes in Fibrolamellar Hepatocellular Carcinoma Treated with Immune Checkpoint Inhibitors.
Chen KY, Popovic A, Hsiehchen D, Baretti M, Griffith P, Bista R, Baghdadi A, Kamel IR, Simon SM, Migler RD, Yarchoan M.
Chen KY, et al. Among authors: bista r.
Cancers (Basel). 2022 Oct 30;14(21):5347. doi: 10.3390/cancers14215347.
Cancers (Basel). 2022.
PMID: 36358766
Free PMC article.
Item in Clipboard
Transarterial Radioembolization Treatment as a Bridge to Surgical Resection in Pediatric Hepatocellular Carcinoma.
Whitlock RS, Loo C, Patel K, Bista R, Goss JA, Heczey A, Khan O, Lopez-Terrada D, Masand P, Nguyen H, Mahvash A, Vasudevan SA, Kukreja K.
Whitlock RS, et al. Among authors: bista r.
J Pediatr Hematol Oncol. 2021 Nov 1;43(8):e1181-e1185. doi: 10.1097/MPH.0000000000002089.
J Pediatr Hematol Oncol. 2021.
PMID: 33769387
Item in Clipboard
Disulfiram overcomes bortezomib and cytarabine resistance in Down-syndrome-associated acute myeloid leukemia cells.
Bista R, Lee DW, Pepper OB, Azorsa DO, Arceci RJ, Aleem E.
Bista R, et al.
J Exp Clin Cancer Res. 2017 Feb 1;36(1):22. doi: 10.1186/s13046-017-0493-5.
J Exp Clin Cancer Res. 2017.
PMID: 28143565
Free PMC article.
Item in Clipboard
Clinical resistance associated with a novel MAP2K1 mutation in a patient with Langerhans cell histiocytosis.
Azorsa DO, Lee DW, Wai DH, Bista R, Patel AR, Aleem E, Henry MM, Arceci RJ.
Azorsa DO, et al. Among authors: bista r.
Pediatr Blood Cancer. 2018 Sep;65(9):e27237. doi: 10.1002/pbc.27237. Epub 2018 May 16.
Pediatr Blood Cancer. 2018.
PMID: 29768711
Item in Clipboard
Rapid Response to Lorlatinib in a Patient With TFG-ROS1 Fusion Positive Inflammatory Myofibroblastic Tumor of the Chest Wall Metastatic to the Brain and Refractory to First and Second Generation ROS1 Inhibitors.
Carcamo B, Bista R, Wilson H, Reddy P, Pacheco J.
Carcamo B, et al. Among authors: bista r.
J Pediatr Hematol Oncol. 2021 Jul 1;43(5):e718-e722. doi: 10.1097/MPH.0000000000002185.
J Pediatr Hematol Oncol. 2021.
PMID: 34157012
Item in Clipboard
Preferences for survivorship education and delivery among Latino and non-Latino childhood cancer survivors and caregivers.
Shakeel O, Aguilar S, Howell A, Ikwuezunma A, Taylor O, Okcu MF, Bista R, Hartley J, Eraña R, Bernini JC, Kahalley L, Scheurer M, Gramatges MM.
Shakeel O, et al. Among authors: bista r.
J Cancer Surviv. 2023 Nov 3:10.1007/s11764-023-01485-z. doi: 10.1007/s11764-023-01485-z. Online ahead of print.
J Cancer Surviv. 2023.
PMID: 37922072
Item in Clipboard
Cite
Cite